TELES Aktiengesellschaft

TLIK

Equity

ISIN DE000A289B07 / Valor 55935164

Xetra (2024-12-23)

EUR 0.62-6.06%

TELES Aktiengesellschaft
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

TELES Aktiengesellschaft, headquartered in Berlin, operates within the pharmaceutical and telecommunications industries, serving a diverse international market. In its pharmaceutical division, TELES specializes in the distribution of prescription medications across various European countries, enhancing the sector's efficiency through a billing service that aids pharmacies in leveraging new business models, including those related to clinical healthcare research. On the telecommunications front, the company focuses on creating digitization solutions tailored for the global market. This includes assisting clients with the setup, execution, and transition to new infrastructure solutions. TELES AG's commitment to innovation and service in both pharmaceuticals and telecommunications is underscored by its listing on the Frankfurt Stock Exchange in the Prime Standard, reflecting its standing and ambition in these sectors.

Summarized from source with an LLMView SourceSector: Telecommunications

Revenue Decline

In the fourth quarter of 2023, TELES Aktiengesellschaft reported a significant decline in revenue. The company's sales amounted to EUR 59.3 million, down from EUR 73.4 million in the previous year. This decrease is primarily attributed to a substantial price increase in the procurement of a cancer drug that was successful in Germany in 2022.

Operating Result

TELES Aktiengesellschaft's operating result (EBIT) for Q4 2023 was EUR -2.4 million, an improvement from the previous year's EBIT of EUR -17.7 million. This improvement is largely due to the sale of the telecommunications segment, which reduced personnel expenses and depreciation costs significantly.

Net Loss

The net loss for TELES Aktiengesellschaft in the fourth quarter of 2023 was EUR 2.9 million, compared to a net loss of EUR 16.6 million in the previous year. The reduction in net loss is attributed to lower depreciation and personnel expenses following the sale of the telecommunications segment.

Balance Sheet

TELES Aktiengesellschaft's balance sheet total decreased by EUR 2.5 million compared to the previous year. Non-current assets increased slightly by EUR 0.2 million to EUR 3.4 million, while current assets decreased by EUR 2.7 million to EUR 8.4 million, mainly due to a reduction in trade receivables.

Equity and Liabilities

The group's equity amounted to EUR -5.1 million in Q4 2023, down from EUR -2.2 million in the previous year. Long-term liabilities increased to EUR 2.6 million from EUR 2.2 million, reflecting the company's ongoing financial restructuring efforts following the sale of its telecommunications segment.

Summarized from source with an LLMView Source

Key figures

-57.2%1Y

-92.7%3Y

-30.8%5Y

Performance

72.6%1Y

95.2%3Y

106%5Y

Volatility